Switch to
More onapp

How to use scorecard? Learn more

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,400 cr, stock is ranked 643
High RiskStock is 3.78x as volatile as Nifty
535.8537.10 (+7.44%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹4,400 cr, stock is ranked 643
High RiskStock is 3.78x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-59.59
PB RatioPB Ratio
2.03
Dividend YieldDiv. Yield
0.31%
Sector PESector PE
40.05
Sector PBSector PB
4.70
Sector Div YldSctr Div Yld
0.78%

Forecast & RatingsDetailed Forecast 

67%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Financial TrendFinancial statements 

20202021202220232.913.523.263.940.040.27-0.46-0.20
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.82%

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.71%

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnSep 23, 2023

Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules". | Download

Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 23, 2023, titled "Strides receives USFDA approval for Icosapent Ethyl Capsules". | Download

Board Meeting Intimation 
Announced OnSep 21, 2023

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 25-Sep-2023 to consider Scheme of arrangement. | Download

STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 25-Sep-2023 to consider Scheme of arrangement. | Download

Cash Dividend 
Ex. DateAug 4, 2023

Final • Div/Share: ₹ 1.5

See all events